» Articles » PMID: 19427197

Overweight, Obesity and Gastric Cancer Risk: Results from a Meta-analysis of Cohort Studies

Overview
Journal Eur J Cancer
Specialty Oncology
Date 2009 May 12
PMID 19427197
Citations 145
Authors
Affiliations
Soon will be listed here.
Abstract

The relationship between excess body weight and gastric cancer risk has not been well studied to date. We therefore carried out a systematic review and meta-analysis of published cohort studies to evaluate the association between excess body weight and gastric cancer risk. An electronic search of the MEDLINE, PubMed, EMBASE and Academic Search Premier (EBSCO) databases, which contain articles published from 1950 onwards, was conducted in order to select studies for this meta-analysis. Ten studies with a total number of 9492 gastric cancer cases and a studied population of 3,097,794 were identified. Overall, excess body weight [body mass index (BMI)25] was associated with an increased risk of gastric cancer [odds ratio (OR)=1.22; 95% confidence intervals (CIs)=1.06-1.41]. Specifically, a stratified analysis showed that excess body weight was associated with an increased risk of cardia gastric cancer [overweight and obese (BMI 25), OR=1.55, 95% CIs=1.31-1.84] and gastric cancer among non-Asians (overweight and obese, OR=1.24, 95% CIs=1.14-1.36); however, the stratified analysis also showed that there was no statistically significant link between excess body weight and gastric cancer in the following subgroups: males (overweight and obese, OR=1.22, 95% CIs=0.96-1.55), females (overweight and obese, OR=1.13, 95% CIs=0.65-1.94), non-cardia gastric cancer (overweight and obese, OR=1.18, 95% CIs=0.96-1.45) and Asians (overweight and obese, OR=1.17, 95% CIs=0.88-1.56). The combined results of this meta-analysis, however, do indicate that overweight and obesity are associated with an increased risk of gastric cancer. The strength of the association also increases with increasing BMI.

Citing Articles

Association Between Dairy Products Consumption and Esophageal, Stomach, and Pancreatic Cancers in the PANESOES Multi Case-Control Study.

Oncina-Canovas A, Torres-Collado L, Garcia-de-la-Hera M, Compan-Gabucio L, Gonzalez-Palacios S, Signes-Pastor A Cancers (Basel). 2025; 16(24.

PMID: 39766051 PMC: 11674531. DOI: 10.3390/cancers16244151.


Causal association between gastrointestinal diseases and coronary artery disease: a bidirectional Mendelian randomization study.

Wang Z, Ban J, Zhou Y, Qie R Front Endocrinol (Lausanne). 2024; 15:1458196.

PMID: 39473508 PMC: 11518705. DOI: 10.3389/fendo.2024.1458196.


Casual effects of type 1 diabetes mellitus on site-specific digestive cancers: a Mendelian randomisation analysis.

Zhao J, Li W, Chen L, Li M, Deng W Front Endocrinol (Lausanne). 2024; 15:1407329.

PMID: 39301314 PMC: 11410686. DOI: 10.3389/fendo.2024.1407329.


Next-Cell Hypothesis: Mechanism of Obesity-Associated Carcinogenesis.

Engin A, Engin A Adv Exp Med Biol. 2024; 1460:727-766.

PMID: 39287871 DOI: 10.1007/978-3-031-63657-8_25.


prescription for preventing and treating postoperative recurrence and metastasis of gastric cancer: a randomized controlled trial protocol.

Cao L, Zhu G, Wang X, Kuang Z, Song X, Ma X Front Oncol. 2024; 14:1326970.

PMID: 39035732 PMC: 11257841. DOI: 10.3389/fonc.2024.1326970.